Business goals cannot always put clients' best interests first. Here's why even the executives leading fast-expanding ...

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced two presentations from ...

Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established ...

In November 2025, Iovance reported that clinical results for IOV-4001, a PD-1 inactivated TIL cell therapy, in previously treated advanced melanoma patients are anticipated in the first quarter of ...

Discover Codexis' Q3 2025 earnings highlights, strategic shift with Merck, and new leadership—positioning for growth in oligonucleotide manufacturing.

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

We keep blaming the wrong things for what ails American health care. This is the real problem—and how to fix it.

Binaytara is excited to announce competitive Implementation Science Research Grants of $25,000 each to support innovative projects that will make a real difference in how we deliver cancer care and ...

Maynard 244 was once again filled with students eager to learn new ways to apply their mathematical and statistical skills in ...

The artificial intelligence platform provider announced the opening of its San Francisco office at 575 Market Street, marking ...

To unlock AI’s full potential, businesses must know when it fits—and when it doesn’t. Tech experts share how to focus AI ...

ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers ...